Physicians and pharmaceutical companies involved in clinical trials with patients with hematological diseases should be aware of these problems and make efforts to attenuate the socioeconomic burden of participation in the trials.
Socioeconomic burden of participation in clinical trials in patients with myeloproliferative neoplasms / Goel, Swati; Paoli, Chiara; Iurlo, Alessandra; Pereira, Arturo; Efficace, Fabio; Barbui, Tiziano; Tefferi, Ayalew; Vannucchi, Alessandro M.; Cervantes, Francisco. - In: EUROPEAN JOURNAL OF HAEMATOLOGY. - ISSN 0902-4441. - ELETTRONICO. - (2017), pp. 1-6. [10.1111/ejh.12887]
Socioeconomic burden of participation in clinical trials in patients with myeloproliferative neoplasms
PAOLI, CHIARA;VANNUCCHI, ALESSANDRO MARIA;
2017
Abstract
Physicians and pharmaceutical companies involved in clinical trials with patients with hematological diseases should be aware of these problems and make efforts to attenuate the socioeconomic burden of participation in the trials.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Goel_et_al-2017-European_Journal_of_Haematology.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
284.02 kB
Formato
Adobe PDF
|
284.02 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
